XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Retained Earnings
Beginning Balance (in shares) at Dec. 29, 2018   12,550,711    
Beginning Balance at Dec. 29, 2018 $ 317,542 $ 126 $ 236,525 $ 80,891
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock compensation 4,167   4,167  
Restricted stock issuance, net (in shares)   60,124    
Restricted stock issuance, net 0 $ 1 (1)  
Stock issuance for acquisitions (in shares)   35,821    
Stock issuance for acquisitions 2,230   2,230  
Proceeds from secondary offering, net of costs (in shares)   11,185    
Payment of contingent consideration with common stock 725   725  
Net income 14,337     14,337
Ending Balance (in shares) at Jun. 29, 2019   12,657,841    
Ending Balance at Jun. 29, 2019 339,001 $ 127 243,646 95,228
Beginning Balance (in shares) at Mar. 30, 2019   12,565,115    
Beginning Balance at Mar. 30, 2019 326,171 $ 126 239,611 86,434
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock compensation 2,369   2,369  
Restricted stock issuance, net (in shares)   66,874    
Restricted stock issuance, net 0 $ 1 (1)  
Stock issuance for acquisitions (in shares)   25,852    
Stock issuance for acquisitions 1,667   1,667  
Payment of contingent consideration with common stock 0      
Net income 8,794     8,794
Ending Balance (in shares) at Jun. 29, 2019   12,657,841    
Ending Balance at Jun. 29, 2019 339,001 $ 127 243,646 95,228
Beginning Balance (in shares) at Dec. 28, 2019   12,852,357    
Beginning Balance at Dec. 28, 2019 355,963 $ 129 251,187 104,647
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock compensation 6,880   6,880  
Restricted stock issuance, net (in shares)   163,835    
Restricted stock issuance, net 0 $ 1 (1)  
Stock issuance for acquisitions (in shares)   12,406    
Stock issuance for acquisitions 558   558  
Proceeds from secondary offering, net of costs (in shares)   5,244    
Payment of contingent consideration with common stock 278   278  
Net income 8,691     8,691
Ending Balance (in shares) at Jun. 27, 2020   13,033,842    
Ending Balance at Jun. 27, 2020 372,370 $ 130 258,902 113,338
Beginning Balance (in shares) at Mar. 28, 2020   12,874,424    
Beginning Balance at Mar. 28, 2020 364,366 $ 129 255,402 108,835
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Stock compensation 3,501   3,501  
Restricted stock issuance, net (in shares)   159,418    
Restricted stock issuance, net 0 $ 1 (1)  
Stock issuance for acquisitions 0      
Payment of contingent consideration with common stock 0      
Net income 4,503     4,503
Ending Balance (in shares) at Jun. 27, 2020   13,033,842    
Ending Balance at Jun. 27, 2020 $ 372,370 $ 130 $ 258,902 $ 113,338